Tilray Brands (TLRY) Exchange Rate Effect (2017 - 2026)
Tilray Brands' (TLRY) quarterly Exchange Rate Effect came in at $166000.0 in Q2 2026, down 96.19% YoY from $4.4 million in Q2 2025, and down 82.62% on a QoQ basis from $955000.0 in Q1 2026.
Tilray Brands (TLRY) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Exchange Rate Effect data on file, last reported at $166000.0 in Q2 2026.
- Quarterly Exchange Rate Effect fell 96.19% year-over-year to $166000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $1.6 million (up 43.01% YoY) and the FY2026 annual result came in at $1.6 million, up 43.01% from the prior year.
- Exchange Rate Effect fell to $166000.0 in Q2 2026, from $955000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $4.4 million in Q2 2025 to a low of -$2.2 million in Q4 2024.
- A 5-year average of $40111.1 and a median of $177000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect slumped 2460.0% — and 2025, when it surged 683.65%.
- Tracing TLRY's Exchange Rate Effect over 5 years: stood at -$980000.0 in 2022, then soared by 109.69% to $95000.0 in 2023, then tumbled by 2460.0% to -$2.2 million in 2024, then surged by 114.14% to $317000.0 in 2025, then plunged by 47.63% to $166000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $166000.0 (Q2 2026), $955000.0 (Q1 2026), and $317000.0 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | 166,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 166,000.00 |
| May 31, 2026 | 166,000.00 |
| Feb 28, 2026 | 955,000.00 |
| Feb 28, 2026 | 955,000.00 |
| Nov 30, 2025 | 317,000.00 |
| Nov 30, 2025 | 317,000.00 |
| Aug 31, 2025 | 188,000.00 |
| Aug 31, 2025 | 188,000.00 |
| May 31, 2025 | 4.35 Mn |
| May 31, 2025 | 4.35 Mn |
| Feb 28, 2025 | -1.93 Mn |
| Feb 28, 2025 | -1.93 Mn |
| Nov 30, 2024 | -2.24 Mn |
| Nov 30, 2024 | -2.24 Mn |
| Aug 31, 2024 | 958,000.00 |
| Aug 31, 2024 | 958,000.00 |
| May 31, 2024 | -746,000.00 |
| May 31, 2024 | -746,000.00 |
| Feb 29, 2024 | -512,000.00 |
| Feb 29, 2024 | -512,000.00 |